Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage Cell Therapeutics (LCTX) Goodwill & Intangibles: 2010-2025

Historic Goodwill & Intangibles for Lineage Cell Therapeutics (LCTX) over the last 15 years, with Sep 2025 value amounting to $42.4 million.

  • Lineage Cell Therapeutics' Goodwill & Intangibles fell 44.84% to $42.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.4 million, marking a year-over-year decrease of 44.84%. This contributed to the annual value of $57.2 million for FY2024, which is 0.04% down from last year.
  • Latest data reveals that Lineage Cell Therapeutics reported Goodwill & Intangibles of $42.4 million as of Q3 2025, which was down 0.00% from $42.4 million recorded in Q2 2025.
  • Lineage Cell Therapeutics' Goodwill & Intangibles' 5-year high stood at $76.8 million during Q1 2021, with a 5-year trough of $10.7 million in Q3 2021.
  • For the 3-year period, Lineage Cell Therapeutics' Goodwill & Intangibles averaged around $65.2 million, with its median value being $76.8 million (2024).
  • Per our database at Business Quant, Lineage Cell Therapeutics' Goodwill & Intangibles crashed by 86.11% in 2021 and then soared by 619.78% in 2023.
  • Over the past 5 years, Lineage Cell Therapeutics' Goodwill & Intangibles (Quarterly) stood at $10.7 million in 2021, then remained steady at $10.7 million in 2022, then skyrocketed by 436.30% to $57.2 million in 2023, then decreased by 0.04% to $57.2 million in 2024, then tumbled by 44.84% to $42.4 million in 2025.
  • Its Goodwill & Intangibles was $42.4 million in Q3 2025, compared to $42.4 million in Q2 2025 and $57.2 million in Q1 2025.